The clinical approach toward giant cell tumor of bone
L Van der Heijden, PDS Dijkstra… - The …, 2014 - academic.oup.com
We provide an overview of imaging, histopathology, genetics, and multidisciplinary
treatment of giant cell tumor of bone (GCTB), an intermediate, locally aggressive but rarely …
treatment of giant cell tumor of bone (GCTB), an intermediate, locally aggressive but rarely …
Giant cell tumor of bone
RE Turcotte - Orthopedic Clinics, 2006 - orthopedic.theclinics.com
Giant cell tumor (GCT) of bone is a benign but locally aggressive tumor that usually involves
the end of long bone. Its histogenesis remains unclear. It is characterized by a proliferation …
the end of long bone. Its histogenesis remains unclear. It is characterized by a proliferation …
Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts
L Hawinkels, M Paauwe, HW Verspaget, E Wiercinska… - Oncogene, 2014 - nature.com
The interaction between epithelial cancer cells and cancer-associated fibroblasts (CAFs)
has a major role in cancer progression and eventually in metastasis. In colorectal cancer …
has a major role in cancer progression and eventually in metastasis. In colorectal cancer …
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh, MA Engelse… - … , and vascular biology, 2006 - Am Heart Assoc
Pericellular proteases play an important role in angiogenesis and vasculogenesis. They
comprise (membrane-type) matrix metalloproteinases [(MT-) MMPs], serine proteases …
comprise (membrane-type) matrix metalloproteinases [(MT-) MMPs], serine proteases …
[HTML][HTML] Giant cell tumour of bone in the denosumab era
Giant cell tumour of bone (GCTB) is an intermediate locally aggressive primary bone tumour,
occurring mostly at the meta-epiphysis of long bones. Overexpression of receptor activator of …
occurring mostly at the meta-epiphysis of long bones. Overexpression of receptor activator of …
Giant cell tumor of bone
WM Mendenhall, RA Zlotecki… - American journal of …, 2006 - journals.lww.com
Objective: To discuss the treatment and outcomes for giant cell tumor (GCT) of bone.
Materials and Methods: Review of the pertinent literature. Results: GCT is a rare benign …
Materials and Methods: Review of the pertinent literature. Results: GCT is a rare benign …
Cathepsin B inhibition limits bone metastasis in breast cancer
Metastasis to bone is a major cause of morbidity in breast cancer patients, emphasizing the
importance of identifying molecular drivers of bone metastasis for new therapeutic targets …
importance of identifying molecular drivers of bone metastasis for new therapeutic targets …
Cathepsin K inhibitors for osteoporosis and potential off-target effects
D Brömme, F Lecaille - Expert opinion on investigational drugs, 2009 - Taylor & Francis
Cathepsin K is a highly potent collagenase and the predominant papain-like cysteine
protease expressed in osteoclasts. Cathepsin K deficiencies in humans and mice have …
protease expressed in osteoclasts. Cathepsin K deficiencies in humans and mice have …
The alkyne moiety as a latent electrophile in irreversible covalent small molecule inhibitors of cathepsin K
E Mons, IDC Jansen, J Loboda… - Journal of the …, 2019 - ACS Publications
Irreversible covalent inhibitors can have a beneficial pharmacokinetic/pharmacodynamics
profile but are still often avoided due to the risk of indiscriminate covalent reactivity and the …
profile but are still often avoided due to the risk of indiscriminate covalent reactivity and the …
Giant cell tumor of bone: a basic science perspective
Comprehending the pathogenesis of giant cell tumor of bone (GCT) is of critical importance
for developing novel targeted treatments for this locally-aggressive primary bone tumor. GCT …
for developing novel targeted treatments for this locally-aggressive primary bone tumor. GCT …